Kiromic BioPharma, Inc. (KRBP)
USD 1.1
(14.58%)
USD 1.1
(14.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 2.79 Million | 2.06 Million | 469.8 Thousand | 200 Thousand | 87.5 Thousand | 80.9 Thousand |
| Gross Profit | -2.79 Million | -2.06 Million | -469.8 Thousand | -200 Thousand | -87.5 Thousand | -80.9 Thousand |
| Operating Expenses | 19.93 Million | 31.11 Million | 25.3 Million | 19.19 Million | 3.7 Million | 3.18 Million |
| Selling, General and Administrative Expenses | 7.51 Million | 17.19 Million | 13.93 Million | 14.14 Million | 2.5 Million | 1.75 Million |
| Research and Development Expenses | 9.62 Million | 13.92 Million | 11.36 Million | 5.05 Million | 1.2 Million | 1.42 Million |
| Other Expenses | - | - | 53.4 Thousand | - | - | - |
| Cost and Expenses | 19.93 Million | 31.11 Million | 25.3 Million | 19.19 Million | 3.7 Million | 3.18 Million |
| Operating Income | -19.93 Million | -31.11 Million | -25.73 Million | -19.19 Million | -3.7 Million | -3.18 Million |
| Interest Expense | -1.85 Million | 166.5 Thousand | 12.2 Thousand | 3300.00 | 22.5 Thousand | 633.1 Thousand |
| Income Tax Expense | - | 3.45 Million | 65.6 Thousand | 3300.00 | 22.5 Thousand | -80.24 Thousand |
| Earnings before Tax | -20.94 Million | -34.73 Million | -25.58 Million | -19.2 Million | -3.72 Million | -3.81 Million |
| Net Income | -21.29 Million | -38.18 Million | -25.65 Million | -19.2 Million | -3.75 Million | -3.81 Million |
| Earnings Per Share Basic | -21.41 | -70.12 | -67.40 | -79.08 | -29.00 | -32.40 |
| Earnings Per Share Diluted | -21.41 | -70.12 | -67.40 | -79.08 | -29.00 | -32.40 |
| Weighted Average Shares Outstanding | 1.09 Million | 544.52 Thousand | 380.6 Thousand | 242.83 Thousand | 129.32 Thousand | 117.76 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.09 Million | 544.52 Thousand | 380.6 Thousand | 242.83 Thousand | 129.32 Thousand | 117.76 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -16.3 Million | -32.49 Million | -25.73 Million | -18.99 Million | -3.61 Million | -3.1 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 557 Thousand | 557 Thousand | 1.13 Million | 2.79 Million | 560.1 Thousand | 695 Thousand |
| Gross Profit | -557 Thousand | -557 Thousand | -1.13 Million | -2.79 Million | -560.1 Thousand | -695 Thousand |
| Operating Expenses | 5.79 Million | 5.11 Million | 5.31 Million | 17.14 Million | 5.55 Million | 4.29 Million |
| Selling, General and Administrative Expenses | 1.66 Million | 2.09 Million | 2.41 Million | - | 2.87 Million | 2.32 Million |
| Research and Development Expenses | 4.13 Million | 3.02 Million | 2.9 Million | - | 2.67 Million | 1.96 Million |
| Other Expenses | 485 Thousand | 36 Thousand | 1.25 Million | - | 1.79 Million | -1.77 Million |
| Cost and Expenses | 6.35 Million | 5.11 Million | 5.31 Million | 19.93 Million | 5.55 Million | 4.29 Million |
| Operating Income | -6.35 Million | -5.11 Million | -5.31 Million | -19.93 Million | -5.55 Million | -4.29 Million |
| Interest Expense | 957 Thousand | -1.07 Million | 632.9 Thousand | -1.85 Million | 433.8 Thousand | 335.4 Thousand |
| Income Tax Expense | 86 Thousand | -557 Thousand | 1.89 Million | 344.7 Thousand | 2.22 Million | 335.4 Thousand |
| Earnings before Tax | -6.82 Million | -6.14 Million | -4.69 Million | -20.94 Million | -4.19 Million | -6.76 Million |
| Net Income | -6.91 Million | -6.14 Million | -4.69 Million | -21.29 Million | -4.19 Million | -6.76 Million |
| Earnings Per Share Basic | -4.59 | -4.71 | -4.27 | - | -3.52 | -6.42 |
| Earnings Per Share Diluted | -4.59 | -4.71 | -4.27 | - | -3.52 | -6.42 |
| Weighted Average Shares Outstanding | 1.5 Million | 1.3 Million | 1.09 Million | 1.09 Million | 1.18 Million | 1.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Million | 1.3 Million | 1.09 Million | 1.09 Million | 1.18 Million | 1.05 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.79 Million | -5.11 Million | -3.5 Million | - | -3.19 Million | -4.1 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
MFDB
ILXP
RRRT
FTBYF
TGAFF
ANO